Posted on 25 March 2015
Tags: generics, India, m&a news, Ranbaxy, sunpharma
Mumbai, India: March 25, 2015 – Sun Pharmaceutical Industries Ltd., begins the integration of Ranbaxy’s business following the successful closure of its merger. The integration, planned by Sun Pharma over many months, will focus on supporting strong growth. Read the full story
Posted on 08 December 2014
Tags: Aspen, generics, south africa
Aspen Pharma, a global branded and generics pharmaceutical manufacturer, has found a place in the top 50 big pharma companies listed by Current Partnering. Read the full story
Posted on 26 November 2014
Tags: Aspen, generics, south africa
Aspen Pharmacare specialises in the production of branded and generic pharmaceuticals and is currently the biggest pharmaceutical company in South Africa taking a 15% share of the total market. Read the full story
Posted on 23 June 2014
Tags: generics, indian, sun
The speciality pharmaceutical company established in 1983 in India has come a long way in the international pharmaceutical industries. The timeline of the company’s business activities since its establishment shows some key partnerships and acquisitions that the company has embarked upon. Read the full story
Posted on 17 June 2014
Tags: CNS, generics, indian, sun
Sun Pharmaceutical has announced 6 M&A deals since 2009. Read the full story
Posted on 03 February 2014
Tags: generics, OTC, Ranbaxy
Ranbaxy is a research based pharmaceutical company with a strong focus on developing generics. Read the full story
Posted on 17 January 2014
Tags: generics, OTC, partnering, Stada
STADA is a major global pharmaceutical company offering generics and OTC products. Read the full story
Posted on 16 January 2014
Tags: generics, M&A, Stada
Stada, one of the leading generic pharmaceuticals internationally, enters into acquisitions to increase its market presence in the branded and generics business. Read the full story
Posted on 16 January 2014
Tags: generics, partnering, Stada
Stada, an international generic pharmaceutical company, focuses on products with off-patent active pharmaceutical ingredients. Read the full story